Get the Stockscreener App
28.11
0.45%
0.125
Artivion Inc stock is traded at $28.11, with a volume of 28,720.
It is up +0.45% in the last 24 hours and up +12.69% over the past month.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
See More
Previous Close:
$27.98
Open:
$27.86
24h Volume:
28,720
Relative Volume:
0.04
Market Cap:
$1.37B
Revenue:
$458.69M
Net Income/Loss:
$11.68M
P/E Ratio:
117.01
EPS:
0.2402
Net Cash Flow:
$14.58M
1W Performance:
-3.55%
1M Performance:
+12.69%
6M Performance:
-26.68%
1Y Performance:
-34.85%
1-Day Range:
$27.86
$28.48
1-Week Range:
$27.77
$30.14
52-Week Range:
$19.16
$48.25
Artivion Inc Stock (AORT) Company Profile
Name
Artivion Inc
Sector
Industry
Phone
(770) 419-3355
Address
1655 ROBERTS BOULEVARD N W, KENNESAW
Compare AORT vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AORT
Artivion Inc
|
28.11 | 1.41B | 458.69M | 11.68M | 14.58M | 0.2402 |
ABT
Abbott Laboratories
|
114.68 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
330.90 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
92.28 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
49.62 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.50 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Artivion Inc Stock (AORT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-10-26 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Aug-13-25 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Jun-17-25 | Initiated | Canaccord Genuity | Buy |
| Oct-23-24 | Initiated | JMP Securities | Mkt Outperform |
| Sep-27-22 | Reiterated | Lake Street | Buy |
| Aug-08-22 | Initiated | Lake Street | Buy |
| Mar-03-22 | Initiated | Stifel | Buy |
View All
Artivion Inc Stock (AORT) Latest News
Artivion CEO James P. Mackin Sells 70,000 Shares of Common Stock at $28.955 Average Price - Kalkine Media
Artivion Inc (AORT) President & CEO James Mackin Sells 70,000 Sh - GuruFocus
Insider Selling: Artivion (NYSE:AORT) CEO Sells $2,026,500.00 in Stock - MarketBeat
Artivion (AORT) Results Review: EPS Falls Short of Its Estimate at the Close; After Results: The Stock Ends Down 0.28% in the Latest ReadingFinancial Summary - Vinanet
Artivion (AORT) Q2 2026 Earnings Call Transcript - AOL.com
Does Revenue Growth Amid New Losses Reshape The Bull Case For Artivion (AORT)? - simplywall.st
Why Artivion (AORT) Stock Is Trading Up Today - Yahoo Finance
Artivion (NASDAQ: AORT) executive moves to sell 70,000 shares - Stock Titan
Summit Creek Advisors LLC Takes Position in Artivion, Inc. $AORT - MarketBeat
Artivion (NYSE:AORT) Stock Price Up 5.7%Still a Buy? - MarketBeat
Canaccord raises Artivion stock price target to $40 on model update - Investing.com
Artivion CFO Lance A. Berry Sells 715 Shares to Cover RSU Tax Withholding - Kalkine Media
Artivion Inc. (AORT) Slides 2.8% to $28.32: Key Support Levels in FocusLow Vol Factor - Vinanet
Artivion EVP, COO, CFO & treasurer Berry sells $20,412 in stock - Investing.com Nigeria
Artivion SVP Andrew Green sells $17,586 of common stock - Investing.com
Artivion SVP Andrew Green sells $17,586 of common stock By Investing.com - Investing.com Canada
Artivion (NYSE: AORT) exec’s 616-share sale is tax-driven - Stock Titan
Artivion (AORT) Declines 1.82% to $28.61, Testing Key Support ZoneDollar Neutral Pair - Vinanet
Artivion (AORT) Edges Lower to $28.89 as Range-Bound Trading PersistsWyckoff Upthrust - Vinanet
5 Revealing Analyst Questions From Artivion’s Q2 Earnings Call - Yahoo Finance
Royal Bank of Canada Purchases 39,553 Shares of Artivion, Inc. $AORT - MarketBeat
Artivion (NYSE:AORT) Rating Lowered to Sell at Wall Street Zen - MarketBeat
ARTIVION, INC. SEC Filing (Aug 14, 2026) - Stock Titan
AORT (AORT) investor files to sell 616 shares after 44,001-share sale - Stock Titan
Artivion (AORT): Nomura entities report 6.5% beneficial stake in 13G/A - Stock Titan
Artivion Inc (AORT) SVP and General Counsel Jean Holloway Sells 977 Shares - GuruFocus
Artivion SVP Jean Holloway sells 977 shares for $27,834 By Investing.com - Investing.com India
Jean Holloway Sells 977 Shares of Artivion (NYSE:AORT) Stock - MarketBeat
Artivion at canaccord growth conference: pipeline drives growth plan By Investing.com - Investing.com Canada
Artivion at canaccord growth conference: pipeline drives growth plan - Investing.com
Artivion SVP Jean Holloway sells 977 shares for $27,834 - Investing.com
Artivion (AORT) Is Up 5.5% After FDA AMDS Approval And Reaffirmed 2026 Revenue GuidanceWhat's Changed - simplywall.st
Artivion, Inc. (AORT) Stock Price, News, Quote & History - ca.finance.yahoo.com
Artivion SVP, General Counsel Jean F. Holloway disposes of 977 common shares for $27,834.73 - Bitget
Can Artivion (NYSE:AORT) Gain Ground on the NYSE Composite? - Kalkine Media
Artivion (NYSE:AORT) Stock Price Up 8.2%What's Next? - MarketBeat
Artivion, Inc. (AORT) Stock Analysis: Strong Buy Ratings Signal Potential Upside of Nearly 60% - DirectorsTalk Interviews
Artivion, Inc. (AORT) stock price, news, quote and history - Yahoo Finance UK
Artivion revenue up 11% to USD 125.8M in Q2 2026 - Medical Buyer
Artivion Inc (AORT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Artivion (AORT) and Globus Medical (GMED) - The Globe and Mail
Artivion (AORT) Stock Can Revenue Growth Outrun Fresh Losses? - Sahm
Canaccord raises Artivion stock price target on acquisition, PMA approval By Investing.com - Investing.com South Africa
Artivion Q2 Earnings Call Highlights - MarketBeat
Artivion Announces Q2 2026 Financial Results: Revenue Increase and Net Loss Amid Endospan Acquisition - Kalkine Media
ARTIVION, INC. 2026: Revenue $125.76M, EPS ($0.28) — 10-Q Summary - TradingView
Long-Term Growth Opportunities Remain for Artivion (AORT) Despite Challenges - Yahoo Finance
A Quick Look at Today's Ratings for Artivion(AORT.US), With a Forecast Between $38 to $45 - Moomoo
Artivion Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Canaccord raises Artivion stock price target on acquisition, PMA approval - Investing.com
Earnings call transcript: Artivion tops Q2 2026 revenue forecast as shares rise - Investing.com Australia
Artivion Inc Stock (AORT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.59%
0.75%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):